The validity and accuracy of the Work Productivity and Activity Impairment questionnaire -: irritable bowel syndrome version (WPAI:IBS)

被引:154
|
作者
Reilly, MC [1 ]
Bracco, A
Ricci, JF
Santoro, J
Stevens, T
机构
[1] Margaret Reilly Associates Inc, New York, NY USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] AGA Clin Res Associates LLC, Egg Harbor, NJ USA
关键词
D O I
10.1111/j.1365-2036.2004.02091.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Irritable bowel syndrome is a common chronic functional gastrointestinal disorder characterized by recurrent abdominal pain and discomfort associated with alterations in bowel habit. Irritable bowel syndrome affects patients' quality of life and increases productivity loss. Aim: To assess validity and accuracy of the Work Productivity and Activity Impairment questionnaire in irritable bowel syndrome as a tool for quantifying the effects of irritable bowel syndrome on productivity and daily activities. Methods: Validity and accuracy were evaluated in 135 irritable bowel syndrome patients relative to three measures of irritable bowel syndrome disease severity; a debriefing questionnaire; retrospective diary; Work Limitations Questionnaire, and an activity impairment measure (Dimensions of Daily Activities). Results: Symptom severity scores, diary scores, Work Limitations Questionnaire and Dimensions of Daily Activities were significant predictors of work productivity and activity impairment questionnaire in irritable bowel syndrome measures of work time missed, and work and activity productivity loss (P = 0.04 to < 0.0001). Impairment due to irritable bowel syndrome was estimated to be 2.9-4.3% for work time missed and 22-32% for impairment at work, the equivalent of 9.7 -14 h lost productivity per week. Activity impairment was 24-41%. Conclusions: Discriminative validity of the Work Productivity and Activity Impairment questionnaire in irritable bowel syndrome was established, making it the only validated tool for measuring the relative differences between disease severity groups and quantifying work productivity loss and activity impairment in irritable bowel syndrome patients.
引用
收藏
页码:459 / 467
页数:9
相关论文
共 50 条
  • [41] Linguistic Validation of the French Canadian Work Productivity and Activity Impairment Questionnaire–General Health Version
    Mary Gawlicki
    Shawn McKown
    Matthew Talbert
    Barbara Brandt
    Eric Bullington
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 600 - 606
  • [42] PROXIMAL GUT MOTOR-ACTIVITY IN IRRITABLE-BOWEL-SYNDROME (IBS) PATIENTS AT HOME AND AT WORK
    KELLOW, JE
    GILL, RC
    WINGATE, DL
    GASTROENTEROLOGY, 1987, 92 (05) : 1463 - 1463
  • [43] The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD)Responsiveness to Change and English Language Validation
    Peter Wahlqvist
    Gordon H. Guyatt
    David Armstrong
    Alessio Degl’Innocenti
    Diane Heels-Ansdell
    Samer El-Dika
    Ingela Wiklund
    Carlo A. Fallone
    Lisa Tanser
    Sander Veldhuyzen van Zanten
    Peggy Austin
    Alan N. Barkun
    Naoki Chiba
    Holger J. Schünemann
    PharmacoEconomics, 2007, 25 : 385 - 396
  • [44] Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD) -: Results from a cross-sectional study
    Wahlqvist, P
    Carlsson, J
    Stålhammar, NO
    Wiklund, I
    VALUE IN HEALTH, 2002, 5 (02) : 106 - 113
  • [45] The work productivity and activity impairment questionnaire for patients with gastroesophageal reflux disease (WPAI-GERD) -: Responsiveness to change and English language validation
    Wahlqvist, Peter
    Guyatt, Gordon H.
    Armstrong, David
    Degl'Innocenti, Alessio
    Heels-Ansdell, Diane
    El-Dika, Samer
    Wiklund, Ingela
    Fallone, Carlo A.
    Tanser, Lisa
    Veldhuyzen van Zanten, Sander
    Austin, Peggy
    Barkun, Alan N.
    Chiba, Naoki
    Schunemann, Holger J.
    PHARMACOECONOMICS, 2007, 25 (05) : 385 - 396
  • [46] THE VALIDITY AND REPRODUCIBILITY OF A WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT INSTRUMENT
    REILLY, MC
    ZBROZEK, AS
    DUKES, EM
    PHARMACOECONOMICS, 1993, 4 (05) : 353 - 365
  • [47] PRELIMINARY VALIDATION OF THE WORK PRODUCTIVITY ACTIVITY IMPAIRMENT (WPAI) IN CAREGIVERS OF CHILDREN HOSPITALIZED FOR RESPIRATORY ILLNESS (WPAI: CHRI) IN GERMANY AND CANADA
    Reilly, M.
    Mitchell, I
    Gooch, K.
    Vo, P.
    Virabhak, S.
    Lorimer, M.
    Ruff, M.
    Seidenberg, J.
    Khong, H.
    VALUE IN HEALTH, 2012, 15 (07) : A650 - A650
  • [48] A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's Disease Version
    Vergara, Mercedes
    Montserrat, Antonia
    Casellas, Francesc
    Villoria, Albert
    Suarez, David
    Maudsley, Michael
    Gallardo, Olga
    Ricart, Elena
    Calvet, Xavier
    VALUE IN HEALTH, 2011, 14 (06) : 859 - 861
  • [49] Linguistic Validation of the French Canadian Work Productivity and Activity Impairment Questionnaire-General Health Version
    Gawlicki, Mary
    McKown, Shawn
    Talbert, Matthew
    Brandt, Barbara
    Bullington, Eric
    DRUG INFORMATION JOURNAL, 2012, 46 (05): : 600 - 606
  • [50] Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome
    Shah, Eric D.
    Wechsler, Emily V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 892 - 893